Web Analytics

Investor Profile

The Invus Group

The Invus Group United States - New York, NY
INVESTOR

1 Disclosed Funding Rounds $112,000,000
8 Participating Investments




Evergreen structure with over $8 billion under management. Offices in New York, Paris, and Hong Kong.

Invested In

Company Date Round Raised
  Neumora October, 17 ,2022 Series B $112,000,000
  Hemab Therapeutics February, 22 ,2023 Series B $135,000,000
  Bicara Therapeutics March, 07 ,2023 Series B $108,000,000
  Ring Therapeutics March, 10 ,2023 Series C $86,500,000
  Convergent Therapeutics, Inc. May, 04 ,2023 Series A $90,000,000
  ElevateBio May, 25 ,2023 Series D $401,000,000
  Triveni Bio October, 27 ,2023 Series A $92,000,000
  Engine Biosciences November, 01 ,2023 Series A $27,000,000